Lisdexamfetamine Dimesylate 43547-0603-10
Generic: Lisdexamfetamine Dimesylate Capsules
- Manufacturer
- Solco Healthcare Us,llc
- Dosage Form
- Capsule
- Route
- Oral
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CII
- Marketing Start
- August 26, 2023
- Listing Expires
- December 31, 2026
- Application
- ANDA216266
Active Ingredients
| Ingredient | Strength |
|---|---|
| Lisdexamfetamine Dimesylate | 20 mg/1 |
Drug Class
Central Nervous System Stimulant [EPC]Central Nervous System Stimulation [PE]
Selected Package
43547-0603-10Selected100 CAPSULE in 1 BOTTLE (43547-603-10)